Oceanit receives U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for the ASSURE-100 rapid antigen test for detection of COVID-19.
Currently browsing: International News
ASSURE In the News
PRESS RELEASE | Oceanit Receives FDA Emergency Use Authorization for ASSURE-100 Rapid COVID-19 Tests
PRESS RELEASE | Oceanit Selected As a Semi-Finalist For the XPRIZE Rapid Covid Testing Competition
Oceanit’s ASSURE-19 Covid-19 test was selected as a semifinalist from a pool of nearly 700 teams from around the world competing for the XPRIZE for Rapid Covid Testing. We will now perform blind proficiency testing on inactive virus samples sent to us by the XPRIZE Foundation as the next step towards becoming a finalist for the award.